Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Polyethylene Terephthalate
91%
Pediatrics
85%
Neoplasm
70%
Fluorodeoxyglucose F 18
59%
Oncology
41%
Radiation Therapy
33%
Diagnostic Imaging
32%
Cancer
31%
Positron Emission Tomography
25%
Computer Assisted Tomography
25%
Low Drug Dose
23%
Hodgkin's Lymphoma
21%
Arm
21%
Breast Cancer
21%
Treatment Response
17%
Image Quality
16%
Recurrent Disease
14%
Clinical Trial
14%
Diseases
13%
Childhood Cancer
13%
Gallium 68
13%
Biological Marker
12%
Gene Mutation
12%
Injury
12%
Cervical Cancer
12%
Diagnostic Accuracy
12%
Single Photon Emission Computed Tomography-Computed Tomography
12%
Neuroendocrine Tumor
10%
Diffuse Large B-Cell Lymphoma
10%
Gynecological Oncology
10%
DNA Template
10%
Kidney Tumour
10%
Thyroid Cancer
10%
Selumetinib
10%
Visceral Fat
10%
Disease Activity
10%
Hematopoietic Stem Cell Transplantation
10%
Dual Energy Computed Tomography
10%
Epidermal Growth Factor Receptor 2
10%
Preoperative Systemic Therapy
10%
Gamma Urogastrone
10%
Magnetic Resonance Enterography
10%
Non-Hodgkin Lymphoma
10%
Mitogen-Activated Protein Kinase
10%
Crohn's Disease
10%
Heart Disease
10%
Positron Emission Tomography - Magnetic Resonance Imaging
10%
Positron Emission Mammography
10%
Liver Metastasis
10%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
75%
Tumor
65%
Pediatric
42%
Oncology
36%
Diagnostic Imaging
32%
PET Image
31%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
28%
Metabolic Tumor Volume
27%
Oncologic
25%
18F-fluorodeoxyglucose (18F-FDG)
25%
Quantitative PET
24%
FDG Uptake
24%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
24%
Total Lesion Glycolysis
21%
Objective Task-based Evaluation
21%
Imaging Recommendations
21%
Observer Performance
21%
18F-FDG PET-CT
19%
Image Quality
19%
Positron Emission Tomography
18%
Segmentation Method
17%
Radiation Dose
17%
Clinical Practice
17%
High Risk
16%
FDG-PET Scan
16%
Multicenter Clinical Trial
16%
Confidence Interval
16%
Working Diagnosis
16%
Imaging Studies
16%
PET Segmentation
15%
Dice Similarity Coefficient
14%
Radiation Therapy
14%
Pediatric Patients
14%
Hodgkin Lymphoma
14%
Deep Learning
14%
Lymphoma
13%
Metabolic
12%
Pediatric Oncology
12%
SPECT-CT
12%
Clinical Trial Data
12%
Imaging Standards
12%
Clinically Significant
12%
Imaging Methods
12%
Genetic Modification
12%
Response Predictors
12%
Imaging Review
12%
Cervical Cancer
12%
Malignancy
12%
Diagnostic Accuracy
12%
PERCIST
12%